{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:48:09Z","timestamp":1789184889439,"version":"build-2803163510"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bcp.2024.116061","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T16:30:41Z","timestamp":1708101041000},"page":"116061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Activin receptors in human cancer: Functions, mechanisms, and potential clinical applications"],"prefix":"10.1016","volume":"222","author":[{"given":"Ruochen","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6072","key":"10.1016\/j.bcp.2024.116061_b0005","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/321776a0","article-title":"Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid","volume":"321","author":"Vale","year":"1986","journal-title":"Nature"},{"issue":"6072","key":"10.1016\/j.bcp.2024.116061_b0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/321779a0","article-title":"Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin","volume":"321","author":"Ling","year":"1986","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2024.116061_b0015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1152\/physrev.00002.2018","article-title":"Activin A in mammalian physiology","volume":"99","author":"Bloise","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2024.116061_b0020","article-title":"Structure and activation of pro-activin A","volume":"7","author":"Wang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2024.116061_b0025","first-page":"8","article-title":"Activins and inhibins: roles in development, physiology, and disease","author":"Namwanje","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2024.116061_b0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4254\/wjh.v1.i1.17","article-title":"Activins and follistatins: Emerging roles in liver physiology and cancer","volume":"1","author":"Kreidl","year":"2009","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.bcp.2024.116061_b0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2353\/ajpath.2009.080296","article-title":"Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo","volume":"174","author":"Gold","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2024.116061_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194798","article-title":"Inhibin \u03b2E (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples","volume":"13","author":"Sugiyama","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2024.116061_b0045","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.molmed.2020.07.009","article-title":"Wound repair, scar formation, and cancer: converging on activin","volume":"26","author":"Cangkrama","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcp.2024.116061_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102314","article-title":"Activin-A in the regulation of immunity in health and disease","volume":"104","author":"Morianos","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bcp.2024.116061_b0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35043051","article-title":"How cells read TGF-beta signals","volume":"1","author":"Massagu\u00e9","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116061_b0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1043-2760(00)00294-0","article-title":"Activin signal transduction pathways","volume":"11","author":"Pangas","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116061_b0065","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0092-8674(93)90488-C","article-title":"Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors","volume":"75","author":"Attisano","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2024.116061_b0070","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/hep.27543","article-title":"Regulatory MiR-148a-ACVR1\/BMP circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma","volume":"61","author":"Li","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2024.116061_b0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.devcel.2019.04.015","article-title":"ALK7 signaling manifests a homeostatic tissue barrier that is abrogated during tumorigenesis and metastasis","volume":"49","author":"Michael","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bcp.2024.116061_b0080","article-title":"Aberrant expression of bone morphogenetic proteins in the disease progression and metastasis of breast cancer","volume":"13","author":"Liu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2024.116061_b0085","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/mc.23601","article-title":"Activin A\/ACVR2A axis inhibits epithelial-to-mesenchymal transition in colon cancer by activating SMAD2","volume":"62","author":"Zhang","year":"2023","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2024.116061_b0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mc.22926","article-title":"LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p\/ACVR2B signaling","volume":"58","author":"Ye","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2024.116061_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1051-0","article-title":"Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude mice","volume":"38","author":"Wu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2024.116061_b0100","first-page":"3441","article-title":"Overexpression of activin receptor-like kinase 7 in breast cancer cells is associated with decreased cell growth and adhesion","volume":"37","author":"Hu","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bcp.2024.116061_b0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.biopha.2017.12.039","article-title":"Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK\/STAT3 signaling pathway in glioma","volume":"98","author":"Song","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116061_b0110","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s11605-020-04889-9","article-title":"Activin a Receptor Type 2A Mutation Affects the Tumor Biology of Microsatellite Instability-High Gastric Cancer","volume":"25","author":"Yuza","year":"2021","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.bcp.2024.116061_b0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.csbj.2019.12.014","article-title":"Deregulated bone morphogenetic proteins and their receptors are associated with disease progression of gastric cancer","volume":"18","author":"Sun","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bcp.2024.116061_b0120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3233\/CBM-150515","article-title":"Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma","volume":"15","author":"Liu","year":"2015","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.bcp.2024.116061_b0125","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.7150\/jca.26790","article-title":"Downregulation of activin A receptor type 2A Is associated with metastatic potential and poor prognosis of colon cancer","volume":"9","author":"Zhuo","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.bcp.2024.116061_b0130","doi-asserted-by":"crossref","unstructured":"Filipponi D, Pagnuzzi-Boncompagni M, Pag\u00e8s G (2022) Inhibiting ALK2\/ALK3 signaling to differentiate and chemo-sensitize medulloblastoma. Cancers (Basel) 14.","DOI":"10.3390\/cancers14092095"},{"key":"10.1016\/j.bcp.2024.116061_b0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ebiom.2019.10.039","article-title":"The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway","volume":"49","author":"Seo","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2024.116061_b0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1242\/jcs.072223","article-title":"MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance","volume":"124","author":"Ye","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2024.116061_b0145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2024.116061_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030516","article-title":"Targeting the activin receptor signaling to counteract the multi-systemic complications of cancer and its treatments","volume":"10","author":"Hulmi","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2024.116061_b0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2024.116061_b0160","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.213512","article-title":"BMPR2 inhibits activin and BMP signaling via wild-type ALK2","volume":"131","author":"Olsen","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2024.116061_b0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mce.2004.03.009","article-title":"Activin isoforms signal through type I receptor serine\/threonine kinase ALK7","volume":"220","author":"Tsuchida","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"issue":"15","key":"10.1016\/j.bcp.2024.116061_b0170","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1101\/gad.201801","article-title":"The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development","volume":"15","author":"Reissmann","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2024.116061_b0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1477-7827-4-52","article-title":"Activin B can signal through both ALK4 and ALK7 in gonadotrope cells","volume":"4","author":"Bernard","year":"2006","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116061_b0180","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78197","article-title":"The orphan ligand, activin C, signals through activin receptor-like kinase 7","volume":"11","author":"Goebel","year":"2022","journal-title":"Elife"},{"issue":"32","key":"10.1016\/j.bcp.2024.116061_b0185","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309967120","article-title":"Activin E-ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice","volume":"120","author":"Adam","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2024.116061_b0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cytogfr.2015.11.005","article-title":"Structural insights into BMP receptors: Specificity, activation and inhibition","volume":"27","author":"Yadin","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bcp.2024.116061_b0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1126\/science.8140412","article-title":"Characterization of type I receptors for transforming growth factor-beta and activin","volume":"264","author":"ten Dijke","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116061_b0200","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1126\/science.8235612","article-title":"Determination of type I receptor specificity by the type II receptors for TGF-beta or activin","volume":"262","author":"Ebner","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116061_b0205","doi-asserted-by":"crossref","first-page":"15438","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","volume":"112","author":"Hino","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2024.116061_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040519","article-title":"Activins as dual specificity TGF-\u03b2 family molecules: SMAD-activation via activin- and BMP-type 1 receptors","volume":"10","author":"Olsen","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2024.116061_b0215","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bone.2017.10.027","article-title":"Variable signaling activity by FOP ACVR1 mutations","volume":"109","author":"Haupt","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2024.116061_b0220","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/en.2015-1747","article-title":"Activin B induces noncanonical SMAD1\/5\/8 signaling via BMP type I receptors in hepatocytes: evidence for a role in hepcidin induction by inflammation in male mice","volume":"157","author":"Canali","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116061_b0225","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1359\/jbmr.060215","article-title":"Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP)","volume":"21","author":"Fiori","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2024.116061_b0230","first-page":"2563","article-title":"MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1","volume":"39","author":"Wang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2024.116061_b0235","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022129","article-title":"Non-Smad Signaling Pathways of the TGF-\u03b2 Family","author":"Zhang","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2024.116061_b0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1091\/mbc.E18-05-0311","article-title":"ACVR1R206H FOP mutation alters mechanosensing and tissue stiffness during heterotopic ossification","volume":"30","author":"Haupt","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bcp.2024.116061_b0245","doi-asserted-by":"crossref","unstructured":"J.A. Valer, C. S\u00e1nchez-de-Diego, C. Pimenta-Lopes, J.L. Rosa, F. Ventura, ACVR1 function in health and disease. Cells 8 (2019).","DOI":"10.3390\/cells8111366"},{"key":"10.1016\/j.bcp.2024.116061_b0250","doi-asserted-by":"crossref","first-page":"28458","DOI":"10.1074\/jbc.M313277200","article-title":"Activin receptor-like kinase-7 induces apoptosis through activation of MAPKs in a Smad3-dependent mechanism in hepatoma cells","volume":"279","author":"Kim","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116061_b0255","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1677\/joe.1.05978","article-title":"Synergistic activity of activin A and basic fibroblast growth factor on tyrosine hydroxylase expression through Smad3 and ERK1\/ERK2 MAPK signaling pathways","volume":"184","author":"Bao","year":"2005","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116061_b0260","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejphar.2016.07.053","article-title":"Activin A stimulates the proliferation and differentiation of cardiac fibroblasts via the ERK1\/2 and p38-MAPK pathways","volume":"789","author":"Hu","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116061_b0265","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yexcr.2014.12.010","article-title":"Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth","volume":"332","author":"Tamminen","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2024.116061_b0270","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbrc.2004.06.083","article-title":"Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1\/2 and deactivating p38 MAP kinase","volume":"320","author":"Huang","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116061_b0275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1128\/MCB.25.1.60-65.2005","article-title":"MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration","volume":"25","author":"Zhang","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116061_b0280","article-title":"Activin B promotes epithelial wound healing in vivo through RhoA-JNK signaling pathway","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2024.116061_b0285","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3727\/096368913X666999","article-title":"Activin B promotes BMSC-mediated cutaneous wound healing by regulating cell migration via the JNK-ERK signaling pathway","volume":"23","author":"Zhang","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bcp.2024.116061_b0290","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1210\/en.2006-0444","article-title":"Activin inhibits the human Pit-1 gene promoter through the p38 kinase pathway in a Smad-independent manner","volume":"147","author":"de Guise","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116061_b0295","doi-asserted-by":"crossref","first-page":"18430","DOI":"10.1074\/jbc.M010768200","article-title":"The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin","volume":"276","author":"Cocolakis","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116061_b0300","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/jcb.20713","article-title":"Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK","volume":"98","author":"Huang","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2024.116061_b0305","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-015-0456-4","article-title":"Activin and TGF\u03b2 use diverging mitogenic signaling in advanced colon cancer","volume":"14","author":"Bauer","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2024.116061_b0310","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1210\/en.2007-1584","article-title":"The role of activin A and Akt\/GSK signaling in ovarian tumor biology","volume":"149","author":"Do","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116061_b0315","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2017.01.011","article-title":"Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling","volume":"391","author":"Dean","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2024.116061_b0320","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.cellsig.2008.05.003","article-title":"Smad2 functions as a co-activator of canonical Wnt\/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300","volume":"20","author":"Hirota","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2024.116061_b0325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1478-811X-7-15","article-title":"Activin signaling as an emerging target for therapeutic interventions","volume":"7","author":"Tsuchida","year":"2009","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2024.116061_b0330","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbrc.2017.08.016","article-title":"Identification of novel ALK2 inhibitors and their effect on cancer cells","volume":"492","author":"Kim","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116061_b0335","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3892\/or.2016.5343","article-title":"DNALK2 inhibits the proliferation and invasiveness of breast cancer MDA-MB-231 cells through the Smad-dependent pathway","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2024.116061_b0340","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3892\/ijo.2016.3802","article-title":"BMP signaling pathways affect differently migration and invasion of esophageal squamous cancer cells","volume":"50","author":"Hu","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bcp.2024.116061_b0345","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12849","article-title":"Upregulation of oncogene Activin A receptor type I by Helicobacter pylori infection promotes gastric intestinal metaplasia via regulating CDX2","volume":"26","author":"Chen","year":"2021","journal-title":"Helicobacter"},{"key":"10.1016\/j.bcp.2024.116061_b0350","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41588-022-01205-w","article-title":"K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas","volume":"54","author":"Jessa","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2024.116061_b0355","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.1158\/0008-5472.CAN-09-2912","article-title":"Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2\/Smad1\/Smad4 to promote ovarian cancer cell proliferation","volume":"69","author":"Herrera","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2024.116061_b0360","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.celrep.2012.07.002","article-title":"Secreted stress-induced phosphoprotein 1 activates the ALK2-SMAD signaling pathways and promotes cell proliferation of ovarian cancer cells","volume":"2","author":"Tsai","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2024.116061_b0365","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1242\/dmm.006593","article-title":"The tumor suppressor gene Trp53 protects the mouse lens against posterior subcapsular cataracts and the BMP receptor Acvr1 acts as a tumor suppressor in the lens","volume":"4","author":"Wiley","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bcp.2024.116061_b0370","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1349-7006.2009.01301.x","article-title":"Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis","volume":"100","author":"Na","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2024.116061_b0375","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2014.16","article-title":"Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin","volume":"4","author":"Olsen","year":"2014","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bcp.2024.116061_b0380","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-13-126","article-title":"Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer","volume":"13","author":"Togashi","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2024.116061_b0385","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.18632\/oncotarget.717","article-title":"MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11","volume":"3","author":"Siragam","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2024.116061_b0390","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fendo.2012.00059","article-title":"Nodal promotes glioblastoma cell growth","volume":"3","author":"De Silva","year":"2012","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bcp.2024.116061_b0395","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.2147\/OTT.S177514","article-title":"Nodal regulates bladder cancer cell migration and invasion via the ALK\/Smad signaling pathway","volume":"11","author":"Li","year":"2018","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.bcp.2024.116061_b0400","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1210\/jc.2002-020527","article-title":"Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells","volume":"87","author":"Danila","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116061_b0405","first-page":"83","article-title":"Nodal and activin receptor-like kinase 7 induce apoptosis in human breast cancer cell lines: Role of caspase 3","volume":"1","author":"Zhong","year":"2009","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116061_b0410","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s12032-011-0114-7","article-title":"Reduced expression of activin receptor-like kinase 7 in breast cancer is associated with tumor progression","volume":"29","author":"Zeng","year":"2012","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bcp.2024.116061_b0415","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3892\/etm.2021.9833","article-title":"Biological effects of NODAL on endometrial cancer cells and its underlying mechanisms","volume":"21","author":"Hong","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bcp.2024.116061_b0420","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1210\/jc.2004-0893","article-title":"Nodal induces apoptosis and inhibits proliferation in human epithelial ovarian cancer cells via activin receptor-like kinase 7","volume":"89","author":"Xu","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116061_b0425","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1091\/mbc.e08-03-0259","article-title":"Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7","volume":"19","author":"Xu","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bcp.2024.116061_b0430","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/ERC-18-0082","article-title":"ALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferation","volume":"25","author":"Principe","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bcp.2024.116061_b0435","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1038\/s41388-018-0543-2","article-title":"ACVR1C\/SMAD2 signaling promotes invasion and growth in retinoblastoma","volume":"38","author":"Asnaghi","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2024.116061_b0440","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.jid.2021.01.028","article-title":"MiR-130a acts as a tumor suppressor MicroRNA in cutaneous squamous cell carcinoma and regulates the activity of the BMP\/SMAD pathway by suppressing ACVR1","volume":"141","author":"Lohcharoenkal","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bcp.2024.116061_b0445","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5223","article-title":"Anti-M\u00fcllerian hormone concentration regulates activin receptor-like kinase-2\/3 expression levels with opposing effects on ovarian cancer cell survival","volume":"59","author":"Chauvin","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bcp.2024.116061_b0450","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbrc.2012.11.011","article-title":"Activin type IB receptor signaling in prostate cancer cells promotes lymph node metastasis in a xenograft model","volume":"430","author":"Nomura","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116061_b0455","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1038\/onc.2017.112","article-title":"Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells","volume":"36","author":"Raja","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2024.116061_b0460","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav6789","article-title":"A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling","volume":"5","author":"Nguyen","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2024.116061_b0465","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/labinvest.2011.116","article-title":"Anti-M\u00fcllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis","volume":"91","author":"Anttonen","year":"2011","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bcp.2024.116061_b0470","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1158\/1541-7786.MCR-05-0174","article-title":"Activin receptor-like kinase 7 induces apoptosis through up-regulation of Bax and down-regulation of Xiap in normal and malignant ovarian epithelial cell lines","volume":"4","author":"Xu","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2024.116061_b0475","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/neuonc\/noac220","article-title":"Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-\u03b2 signaling in recurrent tumors","volume":"25","author":"Kashani","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bcp.2024.116061_b0480","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s42003-019-0420-8","article-title":"ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma","volume":"2","author":"Carvalho","year":"2019","journal-title":"Commun Biol"},{"key":"10.1016\/j.bcp.2024.116061_b0485","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.ymthe.2021.02.016","article-title":"Imbalance of TGF-\u03b21\/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness","volume":"29","author":"Ning","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2024.116061_b0490","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.2147\/OTT.S247757","article-title":"Microsatellite instability-related ACVR2A mutations partially account for decreased lymph node metastasis in MSI-H gastric cancers","volume":"13","author":"Zhao","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bcp.2024.116061_b0495","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/mc.22828","article-title":"Dual role of Par-4 in abrogation of EMT and switching on Mesenchymal to Epithelial Transition (MET) in metastatic pancreatic cancer cells","volume":"57","author":"Katoch","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2024.116061_b0500","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1038\/sj.onc.1210533","article-title":"Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway","volume":"26","author":"Craft","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2024.116061_b0505","doi-asserted-by":"crossref","unstructured":"H. Ungefroren, R. Braun, O. Lapshyna, B. Konukiewitz, U.F. Wellner, H. Lehnert, J.U. Marquardt, Suppressive role of ACVR1\/ALK2 in basal and TGF\u03b21-induced cell migration in pancreatic ductal adenocarcinoma cells and identification of a self-perpetuating autoregulatory loop involving the small GTPase RAC1b. Biomedicines 10 (2022).","DOI":"10.3390\/biomedicines10102640"},{"key":"10.1016\/j.bcp.2024.116061_b0510","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08823-9","article-title":"ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis","volume":"10","author":"Hoeman","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2024.116061_b0515","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12894-020-00617-2","article-title":"miR-185 inhibits prostate cancer angiogenesis induced by the nodal\/ALK4 pathway","volume":"20","author":"Li","year":"2020","journal-title":"BMC Urol."},{"key":"10.1016\/j.bcp.2024.116061_b0520","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.2147\/OTT.S248925","article-title":"miR-148a regulates the stem cell-like side populations distribution by affecting the expression of ACVR1 in esophageal squamous cell carcinoma","volume":"13","author":"Tan","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bcp.2024.116061_b0525","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1177\/15353702211037261","article-title":"Epstein-Barr virus microRNA BART10-3p promotes dedifferentiation and proliferation of nasopharyngeal carcinoma by targeting ALK7","volume":"246","author":"Luo","year":"2021","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bcp.2024.116061_b0530","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.biopha.2018.05.041","article-title":"miR-15a\/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-\u03b2 signaling pathway","volume":"104","author":"Jin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116061_b0535","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/carcin\/bgs126","article-title":"miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms","volume":"33","author":"Senanayake","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2024.116061_b0540","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12964-022-01033-9","article-title":"FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells","volume":"21","author":"Quist-L\u00f8kken","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2024.116061_b0545","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12094-013-1063-8","article-title":"PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer","volume":"16","author":"Li","year":"2014","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bcp.2024.116061_b0550","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1590\/1678-4685-gmb-2017-0332","article-title":"Does the expression of the ACVR2A gene affect the development of colorectal cancer","volume":"42","author":"Wodzi\u0144ski","year":"2019","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.bcp.2024.116061_b0555","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11060-021-03890-9","article-title":"H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients","volume":"155","author":"Vuong","year":"2021","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.bcp.2024.116061_b0560","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2559.2011.03885.x","article-title":"Recurrent copy number gains of ACVR1 and corresponding transcript overexpression are associated with survival in head and neck squamous cell carcinomas","volume":"59","author":"Ambrosio","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.bcp.2024.116061_b0565","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/jcsm.12642","article-title":"ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia","volume":"11","author":"Huot","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bcp.2024.116061_b0570","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2024.116061_b0575","doi-asserted-by":"crossref","unstructured":"A. Karki, N.E. Berlow, J.A. Kim, E. Hulleman, Q. Liu, J.E. Michalek, C. Keller, Receptor-driven invasion profiles in diffuse intrinsic pontine glioma. Neurooncol. Adv. 3 (2021) vdab039.","DOI":"10.1093\/noajnl\/vdab039"},{"key":"10.1016\/j.bcp.2024.116061_b0580","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ccell.2020.02.002","article-title":"Mutant ACVR1 arrests glial cell differentiation to drive tumorigenesis in pediatric gliomas","volume":"37","author":"Fortin","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2024.116061_b0585","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbrc.2010.03.039","article-title":"Activin A induces neuronal differentiation and survival via ALK4 in a SMAD-independent manner in a subpopulation of human neuroblastomas","volume":"394","author":"Suzuki","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116061_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.06.016","article-title":"Activin A promotes ovarian cancer cell migration by suppressing E-cadherin expression","volume":"382","author":"Yi","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2024.116061_b0595","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.cellsig.2016.07.013","article-title":"Growth differentiation factor 8 induces SKOV3 ovarian cancer cell migration and E-cadherin down-regulation","volume":"28","author":"Zhao","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2024.116061_b0600","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/carcin\/bgp217","article-title":"Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration","volume":"31","author":"Romero","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2024.116061_b0605","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/pros.21326","article-title":"Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration","volume":"71","author":"Vo","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2024.116061_b0610","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s43018-022-00408-8","article-title":"Context-dependent tumor-suppressive BMP signaling in diffuse intrinsic pontine glioma regulates stemness through epigenetic regulation of CXXC5","volume":"3","author":"Sun","year":"2022","journal-title":"Nat Cancer"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T12:50:43Z","timestamp":1717851043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":122,"alternative-id":["S0006295224000443"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116061","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activin receptors in human cancer: Functions, mechanisms, and potential clinical applications","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116061"}}